BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Palazzo L, Mikolčević P, Mikoč A, Ahel I. ADP-ribosylation signalling and human disease. Open Biol 2019;9:190041. [PMID: 30991935 DOI: 10.1098/rsob.190041] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 13.0] [Reference Citation Analysis]
Number Citing Articles
1 Kliza KW, Liu Q, Roosenboom LWM, Jansen PWTC, Filippov DV, Vermeulen M. Reading ADP-ribosylation signaling using chemical biology and interaction proteomics. Mol Cell 2021;81:4552-4567.e8. [PMID: 34551281 DOI: 10.1016/j.molcel.2021.08.037] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Leung AKL, Griffin DE, Bosch J, Fehr AR. The Conserved Macrodomain Is a Potential Therapeutic Target for Coronaviruses and Alphaviruses. Pathogens 2022;11:94. [DOI: 10.3390/pathogens11010094] [Reference Citation Analysis]
3 Saw G, Tang FR. Epigenetic Regulation of the Hippocampus, with Special Reference to Radiation Exposure. Int J Mol Sci 2020;21:E9514. [PMID: 33327654 DOI: 10.3390/ijms21249514] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Kamata T, Yang CS, Melhuish TA, Frierson HF Jr, Wotton D, Paschal BM. Post-Transcriptional Regulation of PARP7 Protein Stability Is Controlled by Androgen Signaling. Cells 2021;10:363. [PMID: 33572475 DOI: 10.3390/cells10020363] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
5 Aimi F, Moch H, Schraml P, Hottiger MO. Cytoplasmic ADP-ribosylation levels correlate with markers of patient outcome in distinct human cancers. Mod Pathol 2021;34:1468-77. [PMID: 33742140 DOI: 10.1038/s41379-021-00788-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Pazzaglia S, Pioli C. Multifaceted Role of PARP-1 in DNA Repair and Inflammation: Pathological and Therapeutic Implications in Cancer and Non-Cancer Diseases. Cells 2019;9:E41. [PMID: 31877876 DOI: 10.3390/cells9010041] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 12.0] [Reference Citation Analysis]
7 Nowak K, Rosenthal F, Karlberg T, Bütepage M, Thorsell AG, Dreier B, Grossmann J, Sobek J, Imhof R, Lüscher B, Schüler H, Plückthun A, Leslie Pedrioli DM, Hottiger MO. Engineering Af1521 improves ADP-ribose binding and identification of ADP-ribosylated proteins. Nat Commun 2020;11:5199. [PMID: 33060572 DOI: 10.1038/s41467-020-18981-w] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
8 Suskiewicz MJ, Palazzo L, Hughes R, Ahel I. Progress and outlook in studying the substrate specificities of PARPs and related enzymes. FEBS J 2021;288:2131-42. [PMID: 32785980 DOI: 10.1111/febs.15518] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
9 Boo YC. Mechanistic Basis and Clinical Evidence for the Applications of Nicotinamide (Niacinamide) to Control Skin Aging and Pigmentation. Antioxidants (Basel) 2021;10:1315. [PMID: 34439563 DOI: 10.3390/antiox10081315] [Reference Citation Analysis]
10 Puentes LN, Makvandi M, Mach RH. Molecular Imaging: PARP-1 and Beyond. J Nucl Med 2021;62:765-70. [PMID: 33579802 DOI: 10.2967/jnumed.120.243287] [Reference Citation Analysis]
11 Komirishetty P, Areti A, Arruri VK, Sistla R, Gogoi R, Kumar A. FeTMPyP a peroxynitrite decomposition catalyst ameliorated functional and behavioral deficits in chronic constriction injury induced neuropathic pain in rats. Free Radic Res 2022;:1-13. [PMID: 34991423 DOI: 10.1080/10715762.2021.2010731] [Reference Citation Analysis]
12 De Matteis G, Grandoni F, Zampieri M, Reale A, Scatà MC. New Insights into the Significance of PARP-1 Activation: Flow Cytometric Detection of Poly(ADP-Ribose) as a Marker of Bovine Intramammary Infection. Cells 2021;10:599. [PMID: 33803196 DOI: 10.3390/cells10030599] [Reference Citation Analysis]
13 Manco G, Lacerra G, Porzio E, Catara G. ADP-Ribosylation Post-Translational Modification: An Overview with a Focus on RNA Biology and New Pharmacological Perspectives. Biomolecules 2022;12:443. [DOI: 10.3390/biom12030443] [Reference Citation Analysis]
14 Schuller M, Correy GJ, Gahbauer S, Fearon D, Wu T, Díaz RE, Young ID, Carvalho Martins L, Smith DH, Schulze-Gahmen U, Owens TW, Deshpande I, Merz GE, Thwin AC, Biel JT, Peters JK, Moritz M, Herrera N, Kratochvil HT, Aimon A, Bennett JM, Brandao Neto J, Cohen AE, Dias A, Douangamath A, Dunnett L, Fedorov O, Ferla MP, Fuchs MR, Gorrie-Stone TJ, Holton JM, Johnson MG, Krojer T, Meigs G, Powell AJ, Rack JGM, Rangel VL, Russi S, Skyner RE, Smith CA, Soares AS, Wierman JL, Zhu K, O'Brien P, Jura N, Ashworth A, Irwin JJ, Thompson MC, Gestwicki JE, von Delft F, Shoichet BK, Fraser JS, Ahel I; QCRG Structural Biology Consortium. Fragment binding to the Nsp3 macrodomain of SARS-CoV-2 identified through crystallographic screening and computational docking. Sci Adv 2021;7:eabf8711. [PMID: 33853786 DOI: 10.1126/sciadv.abf8711] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 11.0] [Reference Citation Analysis]
15 Parker CG, Pratt MR. Click Chemistry in Proteomic Investigations. Cell 2020;180:605-32. [PMID: 32059777 DOI: 10.1016/j.cell.2020.01.025] [Cited by in Crossref: 54] [Cited by in F6Publishing: 42] [Article Influence: 27.0] [Reference Citation Analysis]
16 Poltronieri P, Celetti A, Palazzo L. Mono(ADP-ribosyl)ation Enzymes and NAD+ Metabolism: A Focus on Diseases and Therapeutic Perspectives. Cells 2021;10:128. [PMID: 33440786 DOI: 10.3390/cells10010128] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
17 Catara G, Corteggio A, Valente C, Grimaldi G, Palazzo L. Targeting ADP-ribosylation as an antimicrobial strategy. Biochem Pharmacol 2019;167:13-26. [PMID: 31176616 DOI: 10.1016/j.bcp.2019.06.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
18 Boehi F, Manetsch P, Hottiger MO. Interplay between ADP-ribosyltransferases and essential cell signaling pathways controls cellular responses. Cell Discov 2021;7:104. [PMID: 34725336 DOI: 10.1038/s41421-021-00323-9] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Schützenhofer K, Rack JGM, Ahel I. The Making and Breaking of Serine-ADP-Ribosylation in the DNA Damage Response. Front Cell Dev Biol 2021;9:745922. [PMID: 34869334 DOI: 10.3389/fcell.2021.745922] [Reference Citation Analysis]
20 Schuller M, Correy GJ, Gahbauer S, Fearon D, Wu T, Díaz RE, Young ID, Martins LC, Smith DH, Schulze-Gahmen U, Owens TW, Deshpande I, Merz GE, Thwin AC, Biel JT, Peters JK, Moritz M, Herrera N, Kratochvil HT, Aimon A, Bennett JM, Neto JB, Cohen AE, Dias A, Douangamath A, Dunnett L, Fedorov O, Ferla MP, Fuchs M, Gorrie-Stone TJ, Holton JM, Johnson MG, Krojer T, Meigs G, Powell AJ, Rangel VL, Russi S, Skyner RE, Smith CA, Soares AS, Wierman JL, Zhu K, Jura N, Ashworth A, Irwin J, Thompson MC, Gestwicki JE, von Delft F, Shoichet BK, Fraser JS, Ahel I; QCRG Structural Biology Consortium., Johannes Gregor Matthias Rack. Fragment Binding to the Nsp3 Macrodomain of SARS-CoV-2 Identified Through Crystallographic Screening and Computational Docking. bioRxiv 2020:2020. [PMID: 33269349 DOI: 10.1101/2020.11.24.393405] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 3.5] [Reference Citation Analysis]
21 Liu L, Sandow JJ, Leslie Pedrioli DM, Samson AL, Silke N, Kratina T, Ambrose RL, Doerflinger M, Hu Z, Morrish E, Chau D, Kueh AJ, Fitzibbon C, Pellegrini M, Pearson JS, Hottiger MO, Webb AI, Lalaoui N, Silke J. Tankyrase-mediated ADP-ribosylation is a regulator of TNF-induced death. Sci Adv 2022;8:eabh2332. [PMID: 35544574 DOI: 10.1126/sciadv.abh2332] [Reference Citation Analysis]
22 Grimaldi G, Catara G, Palazzo L, Corteggio A, Valente C, Corda D. PARPs and PAR as novel pharmacological targets for the treatment of stress granule-associated disorders. Biochem Pharmacol 2019;167:64-75. [PMID: 31102582 DOI: 10.1016/j.bcp.2019.05.019] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
23 Sinha A, Katyal S, Kauppinen TM. PARP-DNA trapping ability of PARP inhibitors jeopardizes astrocyte viability: Implications for CNS disease therapeutics. Neuropharmacology 2021;187:108502. [PMID: 33631119 DOI: 10.1016/j.neuropharm.2021.108502] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Rosado MM, Pioli C. ADP-ribosylation in evasion, promotion and exacerbation of immune responses. Immunology 2021;164:15-30. [PMID: 33783820 DOI: 10.1111/imm.13332] [Reference Citation Analysis]
25 Schuller M, Ahel I. Beyond protein modification: the rise of non-canonical ADP-ribosylation. Biochem J 2022;479:463-77. [PMID: 35175282 DOI: 10.1042/BCJ20210280] [Reference Citation Analysis]
26 Crawford K, Oliver PL, Agnew T, Hunn BHM, Ahel I. Behavioural Characterisation of Macrod1 and Macrod2 Knockout Mice. Cells 2021;10:368. [PMID: 33578760 DOI: 10.3390/cells10020368] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Ummarino S, Hausman C, Di Ruscio A. The PARP Way to Epigenetic Changes. Genes (Basel) 2021;12:446. [PMID: 33804735 DOI: 10.3390/genes12030446] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
28 Mills A, Gago F. On the Need to Tell Apart Fraternal Twins eEF1A1 and eEF1A2, and Their Respective Outfits. Int J Mol Sci 2021;22:6973. [PMID: 34203525 DOI: 10.3390/ijms22136973] [Reference Citation Analysis]
29 Farooqi AA, Fayyaz S, Poltronieri P, Calin G, Mallardo M. Epigenetic deregulation in cancer: Enzyme players and non-coding RNAs. Semin Cancer Biol 2020:S1044-579X(20)30170-X. [PMID: 32738290 DOI: 10.1016/j.semcancer.2020.07.013] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
30 Salemi M, Mazzetti S, De Leonardis M, Giampietro F, Medici V, Poloni TE, Cannarella R, Giaccone G, Pezzoli G, Cappelletti G, Ferri R. Poly (ADP-ribose) polymerase 1 and Parkinson's disease: A study in post-mortem human brain. Neurochem Int 2021;144:104978. [PMID: 33516746 DOI: 10.1016/j.neuint.2021.104978] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
31 Stévenin V, Neefjes J. Control of host PTMs by intracellular bacteria: An opportunity toward novel anti-infective agents. Cell Chem Biol 2022:S2451-9456(22)00160-X. [PMID: 35512694 DOI: 10.1016/j.chembiol.2022.04.004] [Reference Citation Analysis]
32 Samec M, Liskova A, Koklesova L, Mestanova V, Franekova M, Kassayova M, Bojkova B, Uramova S, Zubor P, Janikova K, Danko J, Samuel SM, Büsselberg D, Kubatka P. Fluctuations of Histone Chemical Modifications in Breast, Prostate, and Colorectal Cancer: An Implication of Phytochemicals as Defenders of Chromatin Equilibrium. Biomolecules 2019;9:E829. [PMID: 31817446 DOI: 10.3390/biom9120829] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
33 Fu W, Yao H, Bütepage M, Zhao Q, Lüscher B, Li J. The search for inhibitors of macrodomains for targeting the readers and erasers of mono-ADP-ribosylation. Drug Discov Today 2021:S1359-6446(21)00239-7. [PMID: 34023495 DOI: 10.1016/j.drudis.2021.05.007] [Reference Citation Analysis]
34 Pears CJ, Brustel J, Lakin ND. Dictyostelium discoideum as a Model to Assess Genome Stability Through DNA Repair. Front Cell Dev Biol 2021;9:752175. [PMID: 34692705 DOI: 10.3389/fcell.2021.752175] [Reference Citation Analysis]
35 Hananya N, Daley SK, Bagert JD, Muir TW. Synthesis of ADP-Ribosylated Histones Reveals Site-Specific Impacts on Chromatin Structure and Function. J Am Chem Soc 2021;143:10847-52. [PMID: 34264659 DOI: 10.1021/jacs.1c05429] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]